D57.459
Sickle-cell thalassemia beta plus with crisis, unspecified
Clinical Classification Guidelines
Inclusion Terms
- HbS-beta plus with crisis with unspecified complication
- Sickle-cell beta plus with crisis with unspecified complication
- Sickle-cell thalassemia beta plus with (painful) crisis NOS
- Sickle-cell thalassemia beta plus with (vaso-occlusive) pain NOS
Medical Intelligence & Overview
Sickle-cell thalassemia beta plus with crisis is a complex blood disorder characterized by abnormal hemoglobin production, leading to the sickling of red blood cells. This condition combines features of sickle-cell disease and thalassemia, a blood disorder involving reduced hemoglobin production. When a crisis occurs, it can cause significant discomfort and complications. The ICD-10 code D57.459 specifically refers to cases where the individual experiences a sickle-cell crisis without a specified type or complication. Proper understanding of this condition can help patients and caregivers in recognizing symptoms and seeking appropriate care.
Causes & Symptoms
Clinical Causes: Inheritance of defective genes from both parents affecting hemoglobin production Presence of abnormal hemoglobin (HbS) combined with thalassemia traits Triggers such as infections, dehydration, extreme physical exertion, cold weather, or stress leading to sickling of red blood cells
Key Symptoms: Severe pain episodes, often in the chest, abdomen, joints, and bones Fatigue and weakness due to anemia Swelling in hands and feet Frequent infections Delayed growth or puberty in children Jaundice or yellowing of the skin and eyes Dizziness or shortness of breath during crises
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves blood tests, including a complete blood count (CBC) and hemoglobin electrophoresis, which determine the types of hemoglobin present. These tests help identify sickle cells and the presence of thalassemia. Additionally, a healthcare provider may perform a physical exam and review medical history to assess the frequency and severity of crisis episodes. Imaging studies, such as ultrasound or X-rays, might be used to evaluate organ involvement if complications are suspected.
Treatment Protocols: Management of sickle-cell thalassemia beta plus with crisis emphasizes controlling symptoms and preventing complications. Treatment options include:
Clinical Advice & FAQs
Billing Guidance
Is D57.459 a billable ICD-10 code?
Yes, D57.459 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D57.459?
Clinical documentation must specify the nature of Sickle-cell thalassemia beta plus with crisis, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference